Elien Heylen

5PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 12, 2024
Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer.

Anaís Sánchez-Castillo, Elien Heylen, Judith Hounjet

|Dec 30, 2023
Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer.

Anaís Sánchez-Castillo, Elien Heylen, Judith Hounjet

|Mar 18, 2023
Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer.

Elien Heylen, Paulien Verstraete, Linde Van Aerschot

|Jan 29, 2021
The ins and outs of serine and glycine metabolism in cancer.

Shauni L Geeraerts, Elien Heylen, Kim De Keersmaecker

|Nov 18, 2020
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth.

Shauni Lien Geeraerts, Kim Rosalie Kampen, Gianmarco Rinaldi

Pageof 1